- Recommendation ID
- TA235/2
- Question
- Further collection of quality of life data from people who are cured and who have experience of amputation and chemotherapy are also needed. Additional data on the health effects on parents, siblings and others with life-threatening illness would also be of value.
- Any explanatory notes
(if applicable) - None.
Source guidance details
- Comes from guidance
- Mifamurtide for the treatment of osteosarcoma
- Number
- TA235
- Date issued
- October 2011
Other details
Is this a recommendation for the use of a technology only in the context of research? | No |
Is it a recommendation that suggests collection of data or the establishment of a register? | Yes |